Vulnerable atherosclerotic plaque features: findings from coronary imaging

被引:5
作者
Osamu Kurihara [1 ]
Masamichi Takano [1 ]
Yasushi Miyauchi [1 ]
Kyoichi Mizuno [2 ]
Wataru Shimizu [3 ]
机构
[1] Cardiovascular Center, Chiba Hokusoh Hospital, Nippon Medical School
[2] Mitsukoshi Health and Welfare Foundation
[3] Division of Cardiology, Nippon Medical School
关键词
ACS; presentation; findings from coronary imaging; Vulnerable atherosclerotic plaque features;
D O I
暂无
中图分类号
R543.5 [动脉疾病];
学科分类号
1002 ; 100201 ;
摘要
Pathological studies have suggested that features of vulnerable atherosclerotic plaques likely to progress and lead to acute cardiovascular events have specific characteristics. Given the progress of intravascular coronary imaging technology, some large prospective studies have detected features of vulnerable atherosclerotic plaques using these imaging modalities.However, the rate of cardiovascular events, such as acute coronary syndrome, has been found to be considerably reduced in the limited follow-up period available in the statin era. Additionally, not all disrupted plaques lead to thrombus formation with clinical presentation. If sub-occlusive or occlusive thrombus formation does not occur, a thrombus on a disrupted plaque will organize without any symptoms, forming a "healed plaque". Although vulnerable plaque detection using intracoronary imaging is focused on "thin-cap fibroatheroma" leading to plaque rupture, superficial plaque erosion is increasingly recognized; however, the underlying mechanism of thrombus formation on eroded plaques is not well understood. One of intravascular imaging, optical coherence tomography(OCT) has the highest image resolution and has enabled detailed characterization of the plaque in vivo.Here, we reviewed the status and limitations of intravascular imaging in terms of detecting vulnerable plaque through mainly OCT studies. We suggested that vulnerable plaque should be reconsidered in terms of eroded plaque and healed plaque and that both plaque and circulating blood should be assessed in greater detail accordingly.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 52 条
[41]   Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA [J].
Sakai, N ;
Uchida, Y ;
Ohashi, K ;
Hibuse, T ;
Saika, Y ;
Tomari, Y ;
Kihara, S ;
Hiraoka, H ;
Nakamura, T ;
Ito, S ;
Yamashita, S ;
Matsuzawa, Y .
JOURNAL OF LIPID RESEARCH, 2003, 44 (06) :1256-1262
[42]  
Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy[J] . Masamichi Takano,Kyoichi Mizuno,Shinya Yokoyama,Koji Seimiya,Fumiyuki Ishibashi,Kentaro Okamatsu,Ryota Uemura.Journal of the American College of Cardiology . 2003 (4)
[43]  
Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions[J] . Frank D. Kolodgie,Allen P. Burke,Andrew Farb,Deena K. Weber,Robert Kutys,Thomas N. Wight,Renu Virmani.Arteriosclerosis Thrombosis and Vascular Biology . 2002 (10)
[44]   The thin-cap fibroatheroma: a type of vulnerable plaque - The major precursor lesion to acute coronary syndromes [J].
Kolodgie, FD ;
Burke, AP ;
Farb, A ;
Gold, HK ;
Yuan, JY ;
Narula, J ;
Finn, AV ;
Virmani, R .
CURRENT OPINION IN CARDIOLOGY, 2001, 16 (05) :285-292
[45]   Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease [J].
Schartl, M ;
Bocksch, W ;
Koschyk, DH ;
Voelker, W ;
Karsch, KR ;
Kreuzer, J ;
Hausmann, D ;
Beckmann, S ;
Gross, M .
CIRCULATION, 2001, 104 (04) :387-392
[46]  
Healed Plaque Ruptures and Sudden Coronary Death[J] . Allen P. Burke,Frank D. Kolodgie,Andrew Farb,Deena K. Weber,Gray T. Malcom,John Smialek,Renu Virmani.Circulation . 2001 (7)
[47]   Lessons from sudden coronary death - A comprehensive morphological classification scheme for atherosclerotic lesions [J].
Virmani, R ;
Kolodgie, FD ;
Burke, AP ;
Farb, A ;
Schwartz, SM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (05) :1262-1275
[48]   Postprandial lipoprotein metabolism and atherosclerosis [J].
Karpe, F .
JOURNAL OF INTERNAL MEDICINE, 1999, 246 (04) :341-355
[49]  
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption[J] . Mann J,Davies M J.Heart (British Cardiac Society) . 1999 (3)
[50]  
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators[J] . Sacks F M,Pfeffer M A,Moye L A,Rouleau J L,Rutherford J D,Cole T G,Brown L,Warnica J W,Arnold J M,Wun C C,Davis B R,Braunwald E.The New England journal of medicine . 1996 (14)